Search Results
C Christofer Juhlin
C Christofer Juhlin
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
Ozgur Mete
Ozgur Mete
Department of Pathology, University Health Network, Toronto, ON, Canada
Endocrine Oncology Site, Princess Margaret Cancer Centre, Toronto, ON, Canada
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
Search for other papers by Ozgur Mete in
Google Scholar
PubMed
Endocrine Oncology Site, Princess Margaret Cancer Centre, Toronto, ON, Canada
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
Search for other papers by Ozgur Mete in
Google Scholar
PubMed
Zubair W Baloch
Zubair W Baloch
Department of Pathology & Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Search for other papers by Zubair W Baloch in
Google Scholar
PubMed
Search for other papers by Zubair W Baloch in
Google Scholar
PubMed
, (2) absence of the conventional nuclear features of papillary carcinoma and (3) presence of at least one of the following: convoluted nuclei; >3 mitoses per 2 mm 2 (10 high-power fields) and tumor necrosis ( Volante et al. 2007 ). However, some
